Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 65

1.

Depression during treatment with interferon alpha.

Schaefer M, Schmidt F, Horn M, Schmid-Wendtner MH, Volkenandt M.

Psychosomatics. 2004 Mar-Apr;45(2):176. No abstract available.

PMID:
15016930
2.

Major depression and risk of depressive symptomatology associated with short-term and low-dose interferon-alpha treatment.

Beratis S, Katrivanou A, Georgiou S, Monastirli A, Pasmatzi E, Gourzis P, Tsambaos D.

J Psychosom Res. 2005 Jan;58(1):15-8.

PMID:
15771865
3.

Novel treatment strategies for depression in patients with hepatitis C.

Loftis JM, Turner EH.

Psychosomatics. 2010 Jul-Aug;51(4):357-8. doi: 10.1176/appi.psy.51.4.357. No abstract available.

PMID:
20587769
4.

Interferon-induced depression in chronic hepatitis C.

Horsmans Y.

J Antimicrob Chemother. 2006 Oct;58(4):711-3. Epub 2006 Sep 2.

PMID:
16951413
5.

Correlation between sICAM-1 and depressive symptoms during adjuvant treatment of melanoma with interferon-alpha.

Schaefer M, Horn M, Schmidt F, Schmid-Wendtner MH, Volkenandt M, Ackenheil M, Mueller N, Schwarz MJ.

Brain Behav Immun. 2004 Nov;18(6):555-62.

PMID:
15331126
6.

Baseline immune activation as a risk factor for the onset of depression during interferon-alpha treatment.

Wichers MC, Kenis G, Leue C, Koek G, Robaeys G, Maes M.

Biol Psychiatry. 2006 Jul 1;60(1):77-9. Epub 2006 Feb 17.

PMID:
16487941
7.

[Depression and suicidal intentions as a side effect of high dosage interferon-alpha therapy--two cases].

Windemuth D, Bacharach-Buhles M, Hoffmann K, Altmeyer P.

Hautarzt. 1999 Apr;50(4):266-9. German.

PMID:
10354918
8.

Cytokine-induced depression during IFN-alpha treatment: the role of IL-6 and sleep quality.

Prather AA, Rabinovitz M, Pollock BG, Lotrich FE.

Brain Behav Immun. 2009 Nov;23(8):1109-16. doi: 10.1016/j.bbi.2009.07.001. Epub 2009 Jul 15.

9.

Major depressive disorder with psychotic features induced by interferon-alpha treatment for hepatitis C in a polydrug abuser.

Kalyoncu OA, Tan D, Mirsal H, Pektas O, Beyazyurek M.

J Psychopharmacol. 2005 Jan;19(1):102-5.

PMID:
15671136
10.

Escitalopram for the prevention of peginterferon-α2a-associated depression in hepatitis C virus-infected patients without previous psychiatric disease: a randomized trial.

Schaefer M, Sarkar R, Knop V, Effenberger S, Friebe A, Heinze L, Spengler U, Schlaepfer T, Reimer J, Buggisch P, Ockenga J, Link R, Rentrop M, Weidenbach H, Fromm G, Lieb K, Baumert TF, Heinz A, Discher T, Neumann K, Zeuzem S, Berg T.

Ann Intern Med. 2012 Jul 17;157(2):94-103. doi: 10.7326/0003-4819-157-2-201207170-00006.

PMID:
22801672
11.

Interferon-alpha. Amarillo Biosciences.

Barnard DL.

Curr Opin Investig Drugs. 2002 May;3(5):693-7.

PMID:
12090541
12.

Three cases of successful tryptophan add-on or monotherapy of hepatitis C and IFNalpha-associated mood disorders.

Schaefer M, Winterer J, Sarkar R, Uebelhack R, Franke L, Heinz A, Friebe A.

Psychosomatics. 2008 Sep-Oct;49(5):442-6. doi: 10.1176/appi.psy.49.5.442.

PMID:
18794514
13.

Prevalence and impact of manic traits in depressed patients initiating interferon therapy for chronic hepatitis C infection.

Lim C, Olson J, Zaman A, Phelps J, Ingram KD.

J Clin Gastroenterol. 2010 Aug;44(7):e141-6. doi: 10.1097/MCG.0b013e3181dc24f8.

PMID:
20495465
14.

Chronic hepatitis C, depression and interferon.

Horsmans Y.

J Hepatol. 2005 Jun;42(6):788-9. Epub 2005 Apr 1. Review. No abstract available.

PMID:
15885347
15.

[Alpha-interferon and mental disorders].

Debien C, De Chouly De Lenclave MB, Foutrein P, Bailly D.

Encephale. 2001 Jul-Aug;27(4):308-17. Review. French.

PMID:
11686052
16.

Differences in depressive thoughts between major depressive disorder, IFN-alpha-induced depression, and depressive disorders among cancer patients.

Pasquini M, Speca A, Mastroeni S, Delle Chiaie R, Sternberg CN, Biondi M.

J Psychosom Res. 2008 Aug;65(2):153-6. doi: 10.1016/j.jpsychores.2008.01.009. Epub 2008 May 21.

PMID:
18655860
17.

Suicidal ideation with IFN-alpha and ribavirin in a patient with hepatitis C.

Ademmer K, Beutel M, Bretzel R, Jaeger C, Reimer C.

Psychosomatics. 2001 Jul-Aug;42(4):365-7. No abstract available. Erratum in: Psychosomatics 2002 Jan-Feb;43(1):88. Clemens J [corrected to Jaeger C].

PMID:
11496031
18.

Interferon-α as an appropriate model of substance-induced depression.

Galvão-de Almeida A, Miranda-Scippa A, De Oliveira IR, Quarantini L.

Psychosomatics. 2011 Jan-Feb;52(1):95. doi: 10.1016/j.psym.2010.11.004. No abstract available.

PMID:
21300205
19.

Lack of association of indoleamine 2,3-dioxygenase polymorphisms with interferon-alpha-related depression in hepatitis C.

Galvão-de Almeida A, Quarantini LC, Sampaio AS, Lyra AC, Parise CL, Paraná R, de Oliveira IR, Koenen KC, Miranda-Scippa A, Guindalini C.

Brain Behav Immun. 2011 Oct;25(7):1491-7. doi: 10.1016/j.bbi.2011.06.001. Epub 2011 Jun 15.

20.

Supplemental Content

Support Center